Get started
Author

Beatriz Canibaño

Observed names: B., Garcia-Cañibano, BEATRIZ CANIBANO, Beatriz Canibano, Beatriz Cannibano, Beatriz Carcia Canibano, Beatriz G. Canibano, Beatriz Garcia Canibano, Beatriz Garcia Cañibano, Beatriz Garcia-Canibano, Beatriz Garcia-Cañibano, Beatriz García Canibano, Canibano Beatriz, Canibano, Beatriz
ORCID: 0000-0002-4316-2953
Observed ORCID: 0000-0002-4316-2953
OpenAlex ID: A5084059265
Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers
2021 · Ajay Vikram Singh, Vaisali Chandrasekar, et al. · ACS Chemical Neuroscience · 158
PDF
Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations
2020 · Beatriz Canibaño, Dirk Deleu, et al. · Journal of Drug Assessment · 69
Peripheral neuropathy in patients with multiple sclerosis
2018 · Adnan Khan, Saadat Kamran, et al. · PLoS ONE · 35
PDF
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
2019 · Raed Alroughani, Jihad Said Inshasi, et al. · Neurology and Therapy · 30
PDF
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
2020 · Raed Alroughani, Jihad Inshasi, et al. · Neurology and Therapy · 28
PDF
Corneal Immune Cells Are Increased in Patients With Multiple Sclerosis
2021 · Adnan Khan, Yi Li, et al. · Translational Vision Science & Technology · 24
Corneal confocal microscopy demonstrates axonal loss in different courses of multiple sclerosis
2021 · Ioannis N. Petropoulos, Kathryn C. Fitzgerald, et al. · Scientific Reports · 22
PDF
Real-world experience of ocrelizumab in multiple sclerosis in an Arab population
2021 · Beatriz Garcia-Cañibano, Sami Ouanes, et al. · Journal of Drug Assessment · 17
Demyelinating Neurological Adverse Events following the Use of Anti-TNF-α Agents: A Double-Edged Sword
2022 · Miral H. Gharib, Mohamed Awni AlKahlout, et al. · Case Reports in Neurological Medicine · 16
PDF
Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case study
2019 · Beatriz Canibaño, Musab Ali, et al. · Case Reports in Women s Health · 16
PDF
Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview
2018 · Dirk Deleu, Boulenouar Mesraoua, et al. · Current Medical Research and Opinion · 14
PDF
Acute Myocardial Injury and Rhabdomyolysis in COVID-19 Patients: Incidence and Mortality
2021 · Liaquat Ali, Imran Mohammed, et al. · Cureus · 13
PDF
Validating Anti-Infective Activity of Pleurotus Opuntiae via Standardization of Its Bioactive Mycoconstituents through Multimodal Biochemical Approach
2021 · Aprajita Tiwari Pandey, Ishan Pandey, et al. · Coatings · 12
PDF
Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity
2020 · Raed Alroughani, Jihad Inshasi, et al. · Postgraduate Medicine · 12
PDF
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
2021 · Jihad Inshasi, Raed Alroughani, et al. · Neurology and Therapy · 11
PDF
Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal study
2023 · Ioannis N. Petropoulos, Fatima Al-Shibani, et al. · Therapeutic Advances in Neurological Disorders · 10
PDF
Corneal immune cells as a biomarker of inflammation in multiple sclerosis: a longitudinal study
2023 · Ioannis N. Petropoulos, Karen John, et al. · Therapeutic Advances in Neurological Disorders · 6
Bilateral Acute Optic Perineuritis Associated With COVID-19 in a Patient With Seronegative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
2021 · Liaquat Ali, Muhammad Naeem, et al. · Cureus · 6
PDF
Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar
2016 · Dirk Deleu, Boulenouar Mesraoua, et al. · Current Medical Research and Opinion · 6
PDF
Real world experience with cladribine tablets in the management of relapsing multiple sclerosis in Qatar
2024 · Beatriz Garcia Cañibano, Lina Okar, et al. · Clinical Neurology and Neurosurgery · 5
Corneal Confocal Microscopy Identifies and Differentiates Patients With Multiple Sclerosis and Epilepsy
2024 · Ioannis N. Petropoulos, Kareem Essam Aly, et al. · Translational Vision Science & Technology · 4
PDF
Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice
2024 · Bassem Yamout, Raed Alroughani, et al. · Neurology and Therapy · 4
A rare presentation of acute flaccid myelitis in covid-19 patient: a case report
2020 · Liaquat Ali, Adnan Khan, et al. · Pakistan Journal of Neurological Sciences · 3
Management of relapsing–remitting multiple sclerosis in Qatar: an expert consensus
2019 · Dirk Deleu, Beatriz Canibaño, et al. · Current Medical Research and Opinion · 3
PDF
Incidence and prevalence of multiple sclerosis in Qatar: A population-based study from 2016 to 2024
2026 · Majd A. AbuAlrob, Rola Khodair, et al. · Multiple Sclerosis and Related Disorders · 2
PDF
Works count: 48
Citation count: 536
H-index: 12
I10-index: 16
Year
Topic
Type